What are the recommended treatment options for molluscum contagiosum?

Recommended Treatment Options for Molluscum Contagiosum

First-Line Treatment Approach

Physical removal methods—including cryotherapy with liquid nitrogen, curettage, or simple excision—are the recommended first-line treatments for molluscum contagiosum, particularly for symptomatic lesions, multiple lesions, or those near the eyes causing conjunctivitis. 1, 2, 3

Physical Removal Methods

• Cryotherapy with liquid nitrogen achieves complete response in approximately 93% of cases and is highly effective as first-line therapy 1
• Curettage, simple excision, or excision with cautery are equally effective physical removal options recommended by the American Academy of Ophthalmology 1, 3
• No anesthesia is typically used for cryotherapy as it has not been shown to be helpful, though treatment success depends heavily on operator skill and complete application 1
• The goal is to achieve visible freezing extending slightly beyond the lesion margin into normal skin 1

Critical caveat: Avoid treating sensitive areas (eyelids, lips, nose, ears) with cryotherapy due to higher risk of complications 1

Topical Chemical Treatments

• 10% potassium hydroxide solution is an effective alternative to cryotherapy in children (86.6% complete response vs 93.3% for cryotherapy) and can be applied at home by parents 1, 2
• Potassium hydroxide confers better cosmetic results than cryotherapy due to lower risk of postinflammatory hyperpigmentation 1
• Salicylic acid is contraindicated in children under 2 years due to risk of systemic toxicity, but may be considered at age 3 with caution 2

FDA-Approved Treatment (2024)

• Berdazimer gel 10.3% (Zelsuvmi) is the first FDA-approved prescription medication for molluscum contagiosum in patients over age 1 year 4
• Applied topically once daily for maximum 12 weeks, it produces nitric oxide with antiviral properties 4
• Most common side effects are localized burning, itching, redness, and irritation at the application site 4
• Expected to be commercially available in the United States by late 2024 4

Treatment Algorithm

Step 1: Assess Disease Extent and Patient Factors

• Confirm diagnosis based on characteristic dome-shaped papules with central umbilication, shiny surface, and skin-colored/whitish/pink appearance 1, 3
• Identify all lesions including nascent ones, as treating all simultaneously reduces recurrence risk 1, 2
• If multiple large lesions with minimal inflammation are present, screen for immunocompromised state 1, 2, 3

Step 2: Determine Treatment Strategy

For limited disease in immunocompetent patients:

• Proceed with physical removal (cryotherapy, curettage, or excision) OR topical 10% potassium hydroxide 1, 2
• Consider FDA-approved berdazimer gel as an at-home option 4

For periocular lesions with conjunctivitis:

• Physical removal is imperative, as conjunctivitis may require weeks to resolve after lesion elimination 1, 3

For extensive or recalcitrant disease:

• Refer to dermatology for comprehensive evaluation 1, 3
• Consider screening for immunodeficiency 1, 2

For immunocompromised patients:

• Severe and recalcitrant lesions may require cidofovir, imiquimod, or interferon 5
• Consider cryptococcal infection in the differential diagnosis for atypical presentations 1

Step 3: Adjunctive Management

• Apply emollients regularly to control xerosis and itching commonly associated with molluscum contagiosum 2
• Reducing viral load through treatment allows the host immune response to eliminate residual virus 1, 2, 3

What NOT to Do

• Do not use imiquimod—it has not shown benefit compared to placebo in randomized controlled trials 1
• Do not use ranitidine or other H2 antagonists—there is no evidence of efficacy 2
• Do not neglect nascent lesions during initial treatment, as this significantly increases recurrence risk 1, 2

Special Considerations

Cosmetic Outcomes

• Cryotherapy may cause postinflammatory hyperpigmentation (most common adverse effect) or uncommonly scarring, particularly concerning for facial lesions or darker skin tones 1
• Hyperpigmentation may persist for 6-12 months 1
• Potassium hydroxide offers superior cosmetic outcomes 1

Watchful Waiting

• Reasonable for asymptomatic, limited disease in immunocompetent patients, as spontaneous resolution typically occurs in 6-12 months (though can take up to 4-5 years) 1
• However, lesions remain infectious throughout their course, increasing transmission risk 1

Pregnancy

• Physical procedures such as cryotherapy are safe to use during pregnancy 5

Follow-Up

• Not usually necessary unless conjunctivitis persists or new lesions develop 1, 3

Transmission Prevention

• Avoid direct skin-to-skin contact with infected individuals 1
• Do not share towels, clothing, or personal items 1
• Keep all lesions covered with waterproof bandages if water exposure is unavoidable 1
• Limit exposure to swimming pools and hot tubs associated with known outbreaks 1
• Hand hygiene with alcohol-based disinfectant or soap and water is the most important prevention method 1